Drugs Made In America Acquisition Corp. (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.33

0.00 (0.00%)

Nov 26, 2025, 4:00 PM EST - Market closed

DMAA Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	1.01	0.48
Operating Expenses	1.01	0.48
Operating Income	-1.01	-0.48
Pretax Income	5.45	-0.48
Net Income	5.45	-0.48
Net Income to Common	5.45	-0.48
Shares Outstanding (Basic)	25	9
Shares Outstanding (Diluted)	25	9
EPS (Basic)	0.22	-0.06
EPS (Diluted)	0.21	-0.06
EBIT	-1.01	-0.48

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q